To identify if estrogen could explain the deregulation of miR-190b between ER+ and ER− breast tumors, we measured its expression levels on the ERα-positive MCF-7 and T-47D breast cancer cell lines treated with 17β-estradiol (E2). This evidence concerns the gene ESR1 and breast carcinoma.